Intelligence Platform
Patents
Browse 183 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10603363
Treatment of retinitis pigmentosa using engineered meganucleases
granted patentUS 10597739
Probiotic bifidobacterium strain
granted patentUS 10562930
Salts and crystal forms of GABAA positive allosteric modulator
granted patentUS 10533040
Colon and pancreas cancer peptidomimetics
granted patentUS 10525248
Apparatus and method for promoting fluid uptake into an implant
granted patentUS 10479868
Polymeric stabilizing formulations
granted patentUS 10422807
Indirect homogeneous mobility shift assays for the detection of biologics in patient sampl
granted patentUS 10364295
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc
granted patentUS 10351628
Antibody fragments, compositions and uses thereof
granted patentUS 10327461
Food thickening agent, method for producing food thickening agent
granted patentUS 10214721
Method for making culture medium
granted patentUS 10195612
Small particle compositions and associated methods
granted patentUS 10105523
Implantable drug delivery device
granted patentUS 10093899
Genetically-modified cells comprising a modified human T cell receptor alpha constant regi
granted patentUS 10093900
Genetically-modified cells comprising a modified human T cell receptor alpha constant regi
granted patentUS 10045943
Implantable medical devices for extended release of therapeutic agents
granted patentUS 10041053
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted patentUS 10023650
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc
granted patentUS 10016388
Ophthalmic lens, intraocular lens, and ophthalmic lens package having ophthalmic lens
granted patentUS 10006052
Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and u
granted patentUS 10000746
LAGLIDADG homing endonuclease cleaving the T cell receptor alpha gene and uses thereof
granted patentUS 9993501
Genetically-modified cells comprising a modified human T cell receptor alpha constant regi
granted patentUS 9993502
Genetically-modified cells comprising a modified human T cell receptor alpha constant regi
granted patentUS 9975952
Antibody fragments, compositions and uses thereof
granted